Adma Biologics Stock Performance

ADMA Stock  USD 15.94  1.58  9.02%   
ADMA Biologics has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.72, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ADMA Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding ADMA Biologics is expected to be smaller as well. ADMA Biologics at this time shows a risk of 2.88%. Please confirm ADMA Biologics treynor ratio, downside variance, and the relationship between the total risk alpha and value at risk , to decide if ADMA Biologics will be following its price patterns.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ADMA Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady primary indicators, ADMA Biologics may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more

Actual Historical Performance (%)

One Day Return
(5.88)
Five Day Return
(2.77)
Year To Date Return
(7.77)
Ten Year Return
197.65
All Time Return
92.87
1
Brokers Suggest Investing in Adma Biologics Read This Before Placing a Bet
12/01/2025
2
Why Adma Biologics Outpaced the Stock Market Today
01/06/2026
3
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
01/12/2026
4
How ADMAs MultiYear Revenue Targets And Margin Push At ADMA Biologics Has Changed Its Investment Story
01/13/2026
5
Assessing ADMA Biologics After Recent Pullback And Strong DCF Upside Potential
01/15/2026
6
ADMA Biologics Is Down 5.0 percent After Expanding Multi-Year Revenue Guidance Targets - Has The Bull Case Changed
01/22/2026
7
Kornitzer Capital Management Inc. KS Acquires 312,115 Shares of ADMA Biologics Inc ADMA
01/28/2026
8
Adma Biologics Stock Moves -1.49 percent What You Should Know - MSN
01/30/2026
Begin Period Cash Flow51.4 M
Total Cashflows From Investing Activities-8.6 M

ADMA Biologics Relative Risk vs. Return Landscape

If you would invest  1,452  in ADMA Biologics on November 7, 2025 and sell it today you would earn a total of  142.00  from holding ADMA Biologics or generate 9.78% return on investment over 90 days. ADMA Biologics is currently generating 0.1939% in daily expected returns and assumes 2.8819% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than ADMA, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days ADMA Biologics is expected to generate 3.77 times more return on investment than the market. However, the company is 3.77 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of risk.

ADMA Biologics Target Price Odds to finish over Current Price

The tendency of ADMA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 15.94 90 days 15.94 
about 85.4
Based on a normal probability distribution, the odds of ADMA Biologics to move above the current price in 90 days from now is about 85.4 (This ADMA Biologics probability density function shows the probability of ADMA Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days ADMA Biologics has a beta of 0.72. This suggests as returns on the market go up, ADMA Biologics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding ADMA Biologics will be expected to be much smaller as well. Additionally ADMA Biologics has an alpha of 0.1759, implying that it can generate a 0.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   ADMA Biologics Price Density   
       Price  

Predictive Modules for ADMA Biologics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ADMA Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
14.8017.4420.08
Details
Intrinsic
Valuation
LowRealHigh
15.7721.5024.14
Details
Naive
Forecast
LowNextHigh
14.6317.2819.92
Details
3 Analysts
Consensus
LowTargetHigh
23.3625.6728.49
Details

ADMA Biologics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. ADMA Biologics is not an exception. The market had few large corrections towards the ADMA Biologics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold ADMA Biologics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of ADMA Biologics within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.18
β
Beta against Dow Jones0.72
σ
Overall volatility
1.68
Ir
Information ratio 0.05

ADMA Biologics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of ADMA Biologics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for ADMA Biologics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Over 94.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Adma Biologics Stock Moves -1.49 percent What You Should Know - MSN

ADMA Biologics Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of ADMA Stock often depends not only on the future outlook of the current and potential ADMA Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ADMA Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding243.3 M
Cash And Short Term Investments103.1 M

ADMA Biologics Fundamentals Growth

ADMA Stock prices reflect investors' perceptions of the future prospects and financial health of ADMA Biologics, and ADMA Biologics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ADMA Stock performance.

About ADMA Biologics Performance

By analyzing ADMA Biologics' fundamental ratios, stakeholders can gain valuable insights into ADMA Biologics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ADMA Biologics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ADMA Biologics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 270.28  294.05 
Return On Tangible Assets 0.37  0.39 
Return On Capital Employed 0.37  0.35 
Return On Assets 0.36  0.38 
Return On Equity 0.65  0.62 

Things to note about ADMA Biologics performance evaluation

Checking the ongoing alerts about ADMA Biologics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ADMA Biologics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 94.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Adma Biologics Stock Moves -1.49 percent What You Should Know - MSN
Evaluating ADMA Biologics' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ADMA Biologics' stock performance include:
  • Analyzing ADMA Biologics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ADMA Biologics' stock is overvalued or undervalued compared to its peers.
  • Examining ADMA Biologics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating ADMA Biologics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of ADMA Biologics' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of ADMA Biologics' stock. These opinions can provide insight into ADMA Biologics' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating ADMA Biologics' stock performance is not an exact science, and many factors can impact ADMA Biologics' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for ADMA Stock analysis

When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes